Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Lidocaine for Analgesia in Bariatric Surgery
NCT03667001Phase 3Completed
- Sponsor
- Miodrag Filipovic
- Start
- Nov 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Lidocaine with Placebo (2 arms). Primary endpoint: Postoperative VAS/NRS Score. Started Nov 2018; status: completed.
02
Drugs
lidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03667001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03667001.